NCT00132418View on ClinicalTrials.gov

Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders

PHASE4CompletedINTERVENTIONAL

Enrollment

564

Participants

Timeline

Start Date

April 30, 2000

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Enbrel

Enbrel

DRUG

Placebo

Placebo

Sponsors

Lead Sponsor

Collaborators (1)

Immunex Corporation

All Listed Sponsors

collaborator

Immunex Corporation

INDUSTRY

lead

Amgen

INDUSTRY